Advanced TMS Therapy

What Is TMS Therapy

Transcranial Magnetic Stimulation (TMS) therapy is a non-invasive procedure used to treat various mental health conditions, notably major depressive disorder (MDD) that doesn’t respond well to traditional treatments like medications or therapy. It involves the use of magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression.

During a TMS session, an electromagnetic coil is placed against the scalp near the forehead, and it delivers repetitive magnetic pulses to stimulate nerve cells in the region of the brain involved in mood regulation and depression. This stimulation is thought to activate regions of the brain that are underactive in depression and help alleviate depressive symptoms.

NeuroStar & TMS Treatment

A New Outlook Recovery Services uses NeuroStar transcranial magnetic stimulation (TMS) to target key areas of the brain. Areas that are under-active in people with depression. It is not electroconvulsive therapy. NeuroStar Advanced Therapy is an innovative, FDA-cleared therapy.

While the exact cause of depression is still not known. The leading scientific theory is that it is due to by an imbalance of the brain’s neurotransmitters. Neurotransmitters are the chemical messengers that send signals between brain cells.

During a NeuroStar treatment session, a magnet, similar to those in a magnetic resonance imaging (MRI) machine, is used to stimulate nerve cells. Stimulate areas of the brain thought to control mood.

TMS therapy activates the natural function of the brain. It uses a non-invasive magnetic field, and is not electroconvulsive therapy. These magnetic pulses have a positive effect on the brain. This as a result makes long-term remission possible.

Because NeuroStar is a non-drug treatment, people don’t experience side effects. Side effects like those associated with antidepressant medications. Precisely targeted NeuroStar Advanced Therapy makes long-term remission possible—which is why it’s the #1 choice of doctors.

Try TMS – A Proven Alternative Treatment for Depression

The 9-question Patient Health Questionnaire (PHQ-9) is a diagnostic tool introduced in 2001 to screen adult patients in a primary care setting for the presence and severity of depression. It rates depression based on the self-administered Patient Health Questionnaire (PHQ). The PHQ is part of Pfizer’s larger suite of trademarked products, called the Primary Care Evaluation of Mental Disorders (PRIME-MD). The PHQ-9 takes less than 3 minutes to complete and simply scores each of the 9 DSM-IV criteria for depression based on the mood module from the original PRIME-MD. Primary care providers frequently use the PHQ-9 to screen for depression in patients.